HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Like Health And Economic Impact, COVID-19 Unprecedented As Unlawful Claims Driver

Executive Summary

Variety of products advertised with false coronavirus claims also grew in FTC's latest warnings submitted. It warned 21 firms on claims for products including IV drips, ozone therapy and stem cell treatments.

You may also be interested in...



US Consumer Health Regulation: Before Warning, Recall For Supplement With COVID-19 Label Claim

Until FDA on 23 June posted report about Golden Nutrition Inc.’s herbal supplement, violative COVID-19 claims had been found online and in advertising through other channels. Other consumer health recalls in US include more than 2.5m bottles of Gaviscon Liquid Antacid missing a safety warning on labels.

US Regulators Shine Warning On Clinic’s Ozone, UV Light, Other Treatments For COVID-19

US FDA and FTC warned a California integrative medicine doctor for offering ozone treatment and UV light therapy to prevent COVID-19 as well as a private blogger and an Amazon vendor who recommended vitamins for preventing the virus.

On Pandemic Alert, Regulators See ‘Yellow Flags’ In Immunity Claims For Supplements

Supplement immunity claims are more likely to get regulators’ attention when they also explain immunity’s importance, often moving into treatment claims, says attorney Justin Prochnow. Hash tags mentioning COVID-19 or staying healthy during the pandemic also can suggest products treat the virus.

Related Content

Topics

UsernamePublicRestriction

Register

SC100339

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel